Módosított Blalock-Taussig-shuntök allograft vena saphena alkalmazásával. Ot év tapasztalatai.

Translated title of the contribution: Modified Blalock-Taussig shunt using a saphenous vein allograft. Five-year experience

G. Bogáts, E. Kertész, M. Katona, A. Tószegi, I. Simonfalvi, G. Kovács

Research output: Contribution to journalArticle

Abstract

From July 1989 to June 1994 23 modified Blalock-Taussig shunts were performed using allograft saphenous veins. Veins stored in Hank's solution were implanted in 8, and cryopreserved ones were used in 15 cases. No operative death, bleeding, or infectious complication has occurred. There were 2 early and 2 late deaths, none was related to shunt occlusion. Clinical, angiographic and echocardiographic investigations proved that the rest of the shunts are still patent and functioning well after an average of 30 months follow up. Histological studies showed that donor cells have been replaced after several months with recipient cells both in the wall and at the luminal surface of the grafts. No difference was found between veins stored in Hank's solution and cryopreserved grafts concerning clinical outcome and histology.

Translated title of the contributionModified Blalock-Taussig shunt using a saphenous vein allograft. Five-year experience
Original languageHungarian
Pages (from-to)1263-1266
Number of pages4
JournalOrvosi hetilap
Volume136
Issue number24
Publication statusPublished - Jun 11 1995

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint Dive into the research topics of 'Modified Blalock-Taussig shunt using a saphenous vein allograft. Five-year experience'. Together they form a unique fingerprint.

  • Cite this